← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2016Last known activity
Mar 30, 2017
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT03082196Lead sponsorPhase 2Mar 30, 2017
- NCT02645617Overall official - principal investigatorPhase 1Jun 1, 2016
- NCT02645617Lead sponsorPhase 1Jun 1, 2016
- NCT02536040Study directorPhase 3Jan 1, 2016
- NCT02536040Lead sponsorPhase 3Jan 1, 2016
Details
- Last known activity
- Mar 30, 2017